Conexeu Sciences Inc. (CNXU) Balance Sheet
CNXU balance sheet, FY2025
October 31, 2025 · U.S. dollars$7.7M assets = $336,018 liabilities + $7.4M equity
Both columns are drawn to the same scale: what CNXU owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CNXU financial health
Descriptive bands, not a rating. Fiscal FY2025.
CNXU balance sheet trends, FY2024–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $533,940FY2024 | $7.7MFY2025 | +1,340.0%/yr | |
| Total liabilities | $438,976FY2024 | $336,018FY2025 | −23.5%/yr | |
| Shareholders’ equity | $94,964FY2024 | $7.4MFY2025 | +7,642.6%/yr | |
| Cash & short-term investments | $314,616FY2024 | $4.8MFY2025 | +1,428.5%/yr | |
| Working capital | $6,378FY2024 | $7.1MFY2025 | +$7.1M | |
| Book value per share | $0.00FY2024 | $0.35FY2025 | +7,642.6%/yr | |
| Shares outstanding | 20.9MFY2024 | 20.9MFY2025 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CNXU assets
CNXU liabilities and equity
CNXU debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CNXU balance sheet
| FY2025 | FY2024 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $4.8M | $314,616 |
| Cash & equivalents | $4.8M | $314,616 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other current assets | $2.6M | $32,621 |
| Total current assets | $7.5M | $347,237 |
| Property, plant & equipment (net) | $11,237 | $0 |
| Goodwill & intangible assets | $176,884 | $186,703 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $42,177 | $0 |
| Total assets | $7.7M | $533,940 |
| Liabilities | ||
| Accounts payable | $256,296 | $319,024 |
| Total current liabilities | $336,018 | $340,859 |
| Long-term debt | $0 | $98,117 |
| Other long-term liabilities | $0 | $0 |
| Total liabilities | $336,018 | $438,976 |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$4.5M | −$597,963 |
| Total shareholders' equity | $7.4M | $94,964 |
| Key figures | ||
| Total debt | — | $98,117 |
| Net cash (debt) | — | $216,499 |
| Working capital | $7.1M | $6,378 |
| Tangible book value | $7.2M | −$91,739 |
| Book value per share | $0.35 | $0.00 |
| Shares outstanding | 20.9M | 20.9M |
| Current ratio | 22.20 | 1.02 |
| Quick ratio | 14.31 | 0.92 |
| Debt / equity | — | 1.03 |
| Equity / assets | 95.6% | 17.8% |
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | $2.0M | $6.8M | $6.3M | $4.8M |
| Cash & equivalents | $2.0M | $6.8M | $6.3M | $4.8M |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other current assets | $4.8M | $1.1M | $1.2M | $2.6M |
| Total current assets | $6.8M | $7.9M | $7.5M | $7.5M |
| Property, plant & equipment (net) | $145,959 | $38,400 | $11,144 | $11,237 |
| Goodwill & intangible assets | $163,996 | $163,949 | $172,541 | $176,884 |
| Long-term investments | $71,328 | $71,328 | $0 | $0 |
| Other non-current assets | $18,475 | $12,317 | $60,401 | $42,177 |
| Total assets | $7.2M | $8.2M | $7.7M | $7.7M |
| Liabilities | ||||
| Accounts payable | $829,532 | $526,364 | $399,297 | $256,296 |
| Total current liabilities | $1.3M | $1.0M | $876,275 | $336,018 |
| Long-term debt | $0 | $0 | $0 | $0 |
| Lease obligations | $72,482 | — | — | — |
| Other long-term liabilities | $33,233 | $0 | $0 | $0 |
| Total liabilities | $1.3M | $1.0M | $876,275 | $336,018 |
| Shareholders' equity | ||||
| Retained earnings (deficit) | −$16.3M | −$8.5M | −$6.2M | −$4.5M |
| Total shareholders' equity | $5.9M | $7.2M | $6.8M | $7.4M |
| Key figures | ||||
| Working capital | $5.5M | $6.9M | $6.6M | $7.1M |
| Tangible book value | $5.7M | $7.0M | $6.7M | $7.2M |
| Book value per share | $0.21 | $0.34 | $0.33 | $0.35 |
| Shares outstanding | 27.4M | 20.9M | 20.9M | 20.9M |
| Current ratio | 5.31 | 7.89 | 8.51 | 22.20 |
| Quick ratio | 1.55 | 6.83 | 7.14 | 14.31 |
| Equity / assets | 81.8% | 87.8% | 88.6% | 95.6% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
CNXU financial position
At the end of fiscal 2025 (October 31, 2025), Conexeu Sciences had total assets of $7.7 million (up 1,340.0% from a year earlier), total liabilities of $0.3 million and shareholders' equity of $7.4 million. Its current ratio was 22.20. In the latest quarter (ended July 31, 2026) total assets were $7.2 million and equity $5.9 million.
Related: CNXU income statement, CNXU cash flow statement, CNXU key metrics. See the CNXU stock overview for the latest quote and news.
CNXU balance sheet FAQ
What are Conexeu Sciences's total assets?
Conexeu Sciences reported total assets of $7.7 million at the end of fiscal 2025 (October 31, 2025), compared with $0.5 million a year earlier.
How much cash does Conexeu Sciences have?
Conexeu Sciences held $4.8 million in cash and short-term investments at the end of fiscal 2025.
What is Conexeu Sciences's book value?
Conexeu Sciences's shareholders' equity (book value) was $7.4 million at the end of fiscal 2025, or $0.35 per share.
What is Conexeu Sciences's current ratio?
Conexeu Sciences had current assets of $7.5 million and current liabilities of $0.3 million, a current ratio of 22.20 (it can cover its short-term obligations).
How much goodwill does Conexeu Sciences have?
Conexeu Sciences carried $0.2 million of goodwill and intangible assets, 2.3% of total assets, at the end of fiscal 2025.